Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium nitrite oral - Theravasc

X
Drug Profile

Sodium nitrite oral - Theravasc

Alternative Names: JAN-101; JAN101 SR; TV-1001; TV1001SR

Latest Information Update: 24 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LSU Health Shreveport
  • Developer TheraVasc; University of Colorado at Boulder
  • Class Antidotes; Antihypertensives; Antivirals; Nitrites; Small molecules; Sodium compounds; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Membrane fusion protein inhibitors; Nitric oxide donors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Diabetic neuropathies; Peripheral arterial disorders
  • Phase I/II Vascular disorders
  • No development reported Systemic scleroderma

Most Recent Events

  • 21 Sep 2023 Efficacy data from a phase II trial in Diabetic neuropathies in USA (PO) released by TheraVasc
  • 01 Aug 2023 University of Alabama at Birmingham plans a phase I trial for pain in August 2023 (PO) (NCT05893160)
  • 28 Sep 2022 No recent reports of development identified for preclinical development in Systemic-scleroderma in USA (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top